Purpose
To determine whether the suppression of asymptomatic or mildly symptomatic arrhythmias after MI, by moricizine, reduces the
mortality rate in arrhythmia
References
The Cardiac Arrhythmia Suppression Trial II investigators: Effect of the antiarrhythmic agent moricizine on survival after
myocardial infarction. N Engl J Med 1992, 327:227–233.
Brooks MM, Gorkin L, Schron EB, et al: Moricizine and quality of life in the cardiac arrhythmia suppression trial II.
Control Clin Trials 1994, 15:437–449.
|
Farmacêutica